Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Organogenesis Holdings stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ORGO.
You can purchase shares of Organogenesis Holdings (NASDAQ:ORGO) through any online brokerage.
Other companies in Organogenesis Holdings’s space includes: Immunome (NASDAQ:IMNM), KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Cogent Biosciences (NASDAQ:COGT) and Replimune Group (NASDAQ:REPL).
Organogenesis Holdings has a consensus price target of $5.50.
The stock price for Organogenesis Holdings (NASDAQ: ORGO) is $5.31 last updated May 2, 2025 at 4:00 PM EDT.
There are no upcoming dividends for Organogenesis Holdings.
Organogenesis Holdings’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for Organogenesis Holdings.
Organogenesis Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.